MARC details
000 -LEADER |
fixed length control field |
05368cam a2200781 i 4500 |
001 - CONTROL NUMBER |
control field |
on1080548053 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240228144917.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
200109s2019 si ac b 000 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2019933573 |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
101760581 |
Source |
DNLM |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9789811363542 |
Qualifying information |
|
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9811363544 |
Qualifying information |
|
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Canceled/invalid ISBN |
9789811363559 |
Qualifying information |
|
029 0# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
OCLC library identifier |
NLM |
System control number |
101760581 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1080548053 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
NLM |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
NLM |
Modifying agency |
OCLCO |
-- |
OCLCA |
-- |
UKQUB |
-- |
OCLCO |
-- |
OCLCF |
-- |
S2H |
-- |
YDX |
-- |
OCLCO |
-- |
SBI |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
SBIM |
050 ## - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS380.P314.P733 2019 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Patra, Jayanta Kumar, |
Relator term |
|
9 (RLIN) |
1031 |
245 12 - TITLE STATEMENT |
Title |
A practical guide to pharmacological biotechnology / |
Statement of responsibility, etc. |
Jayanta Kumar Patra, Swagat Kumar Das, Gitishree Das, Hrudayanath Thatoi. |
Medium |
[print] |
260 #1 - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Singapore : |
Name of publisher, distributor, etc. |
Springer, |
Date of publication, distribution, etc. |
(c)2019. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xiii, 142 pages : |
Other physical details |
illustrations ; |
Dimensions |
24 cm. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
490 1# - SERIES STATEMENT |
Series statement |
Learning materials in biosciences, |
ISBN |
2509-6125 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PART 1. |
505 0# - FORMATTED CONTENTS NOTE |
Title |
Introduction -- |
-- |
1.1 Rules of laboratory safety in a pharmacology laboratory -- |
-- |
1.2 Commom instruments and their uses used in a pharmacology laboratory |
505 0# - FORMATTED CONTENTS NOTE |
Miscellaneous information |
_______________________________________________ |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PART 2. |
505 0# - FORMATTED CONTENTS NOTE |
Title |
General aspects of Pharmacology laboratory -- |
-- |
2.1 Safety and Risk assessment -- |
-- |
2.2 Use and Handling of laboratory animals -- |
-- |
2.3 Experimental design -- |
-- |
2.4 Essential statistics -- |
-- |
2.5 Cumulative Dose Response Curve -- |
-- |
2.6 Toxicology -- |
-- |
2.7 Basic instruments and techniques in Pharmacology Laboratory |
505 0# - FORMATTED CONTENTS NOTE |
Miscellaneous information |
_______________________________________________ |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PART 3. |
505 0# - FORMATTED CONTENTS NOTE |
Title |
Isolated tissues and organs -- |
-- |
3.1 Basic instruments used for isolated tissue experiments -- |
-- |
3.2 Organ baths -- |
-- |
3.3 Smooth muscle preparations -- |
-- |
3.4 Skeletal muscle preparations -- |
-- |
3.5 Cardiac muscle preparations |
505 0# - FORMATTED CONTENTS NOTE |
Miscellaneous information |
_______________________________________________ |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PART 4. |
505 0# - FORMATTED CONTENTS NOTE |
Title |
Isolated tissues for screening of drugs -- |
-- |
4.1 Evaluation of antidiabetic agents -- |
-- |
4.2 Evaluation of antidepressants -- |
-- |
4.3 Evaluation of antihypertensive agents -- |
-- |
4.4 Evaluation of antiulcer agents -- |
-- |
4.5 Evaluation of hepatotoxicity -- |
-- |
4.6 Evaluation of Antioxidant agents -- |
-- |
4.7 Evaluation of local anaesthetics |
505 0# - FORMATTED CONTENTS NOTE |
Miscellaneous information |
_______________________________________________ |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PART 5. |
505 0# - FORMATTED CONTENTS NOTE |
Title |
Genotoxicity and Toxicological studies -- |
-- |
5.1 The Mouse Lymphoma Assay -- |
-- |
5.2 The Comet Assay -- |
-- |
5.3 In vitro Genotoxicity assay -- |
-- |
5.4 In vitro Teratogenicity Testing -- |
-- |
5.5 Histopathological studies of animal tissues -- |
-- |
5.6 Drug poisoning |
505 0# - FORMATTED CONTENTS NOTE |
Miscellaneous information |
_______________________________________________ |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PART 6. |
505 0# - FORMATTED CONTENTS NOTE |
Title |
Experimental Animal studies -- |
-- |
6.1 Pyrogen testing -- |
-- |
6.2 Collecting blood from mice -- |
-- |
6.3 Studies on different parameters of blood -- |
-- |
6.4 Experiment on central nervous system -- |
-- |
6.5 Evaluation on cardiovascular system -- |
-- |
6.6 Experiments on GI tract |
505 0# - FORMATTED CONTENTS NOTE |
Miscellaneous information |
_______________________________________________ |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PART 7.Clinical trials -- |
Title |
7.1 Clinical Pharmacology and its genesis -- |
-- |
7.2 National and International agencies and their role in Clinical pharmacology -- |
-- |
7.3 Stages in drug development and clinical trials -- |
-- |
7.4 Ethics in Clinical research -- |
-- |
7.5 Safety assessment in Clinical trials |
505 0# - FORMATTED CONTENTS NOTE |
Miscellaneous information |
_______________________________________________ |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PART 8. |
505 0# - FORMATTED CONTENTS NOTE |
Title |
IPR and ethics in animal studies -- |
-- |
8.1 Intellectual property rights and its different categories -- |
-- |
8.2 Importance of IPR in drug development -- |
-- |
8.3 Patenting cells, cell lines and animals -- |
-- |
8.4 Ethics in laboratory animal studies -- |
-- |
8.5 Risk assessment and management -- |
-- |
8.6 Good laboratory practices. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Pharmacological biotechnology is applied to and used to study drug development, working mechanisms, diagnosis, and therapies. This manual is the textbook covering the whole range of experiments related to pharmacology. It also contains basic laboratory safety guidelines along with the basic calculations and formulas used in a laboratory. Each chapter starts with an introduction/theory into the basic approach followed by detailed methods sections with easy-to-follow protocols and comprehensive troubleshooting, calculations and possible questions for examination. The target group is researchers who are studying pharmacological biotechnology in the laboratory. |
530 ## - COPYRIGHT INFORMATION: |
COPYRIGHT INFORMATION |
COPYRIGHT NOT covered - Click this link to request copyright permission: |
Uniform Resource Identifier |
<a href="b">b</a> |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biopharmaceutics. |
9 (RLIN) |
1032 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Medical laboratories. |
9 (RLIN) |
1033 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical biotechnology. |
9 (RLIN) |
1034 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical technology. |
9 (RLIN) |
1035 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacology. |
9 (RLIN) |
1036 |
655 #0 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
BioMed |
655 #0 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Nursing |
9 (RLIN) |
347 |
655 #0 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Theology & Religion |
9 (RLIN) |
312 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Das, Gitishree, |
Relator term |
|
9 (RLIN) |
1037 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Das, Swagat Kumar, |
Relator term |
|
9 (RLIN) |
1038 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Thatoi, H. N., |
Relator term |
|
9 (RLIN) |
1039 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Learning materials in biosciences. |
International Standard Serial Number |
2509-6133 |
9 (RLIN) |
909 |
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
c |
1 |
d |
CYNTHIA SNELL |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Nursing-Reference (LIBRARY USE ONLY) |
VENDOR |
|
Classification part |
RS |
Delivery Date: ACADEMIC YEAR - ie 2022-2023 |
2021-2022 |
COST |
106.79 |
PUBLICATION YEAR |
2019 |
print -BUDGET LINE 10-1411-7022-? |
NURS |
REQUESTED BY: |
NURSING DEPARTMENT |
INVOICE NUMBER: |
349620 |
Source of classification or shelving scheme |
|
REPLACEMENT COST (GET FROM AMAZON) |
90.00 |